Press releases
- New Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors Determine the Severity of Asthma Attacks in Pediatric Patients
- Masimo Reports First Quarter 2022 Financial Results
- Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers
- Masimo SedLine® Brain Function Monitoring Reduced the Use of Anesthetic Agents and Opioids in a Study on Patients Undergoing Cardiac Surgery
- New JAMA Article Highlights the Outcome and Safety Benefits of Remote Patient Monitoring During the Pandemic and Beyond
- Masimo Closes Acquisition of Sound United
- Masimo Announces Certain Preliminary First Quarter 2022 Financial Results and Reaffirms Full-Year 2022 Revenue Guidance
- New Study Finds That Noninvasive and Continuous Hemoglobin Improved Transfusion Management and Outcomes in Pediatric Patients
More ▼
Key statistics
On Friday, Masimo Corp (M2AS34:SAO) closed at 24.02, -17.17% below its 52-week high of 29.00, set on Feb 17, 2022.
52-week range
Markit short selling activity
Open | 24.02 |
---|---|
High | 24.02 |
Low | 24.02 |
Bid | -- |
Offer | -- |
Previous close | 23.78 |
Average volume | 6.22 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 24 2022 20:21 BST.
More ▼